Effective August 2, 2022, mdxhealth has acquired the Oncotype DX GPS (Genomic Prostate Score) test from Exact Sciences. To help ensure a smooth transition for patients, continue to place orders for this test through the existing Exact Sciences portal until further notice. Additionally, Genomic Health Inc, part of Exact Sciences, will continue to perform the Oncotype DX GPS test during the transition. Further communications explaining transition plans will be provided in the coming months. For more details, please review the following press release. Questions? Email: gps@mdxhealth.com

Jake Orville


Joined Exact Sciences: 2019

Jake Orville serves as our General Manager, Screening. He previously served as General Manager, Pipeline since February 2019. Prior to joining Exact Sciences, Mr. Orville served as General Manager, Cardiometabolic & Endocrinology Franchise at Quest Diagnostics, Inc., In 2008, Mr. Orville co-founded Cleveland HeartLab, Inc., and served as its Chief Executive Officer through 2017 when Cleveland HeartLab was acquired by Quest. Earlier in his career Mr. Orville served in leadership and operational roles at NextGen Sciences, Inc., and Third Wave Technologies, Inc. Mr. Orville holds a bachelor's degree from the University of Massachusetts-Amherst and a Master of Business Administration from the University of Wisconsin-Madison. Mr. Orville currently serves as a board member of the Wisconsin Women’s Health Foundation.